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INTRODUCTION 
Gas-filled microbubbles have been recently employed in therapeutic applications due to their unique 
cavitation and sonoporation properties1,2. Local microbubble cavitation by spatially focused ultrasound 
can be applied in achieving site-specific release of incorporated drugs or genes inside microbubbles. 
Microbubbles can potentially be visualized by MRI and serve as an intravascular susceptibility contrast 
agent in vivo due to the induction of large local magnetic susceptibility difference by the gas-liquid 
interface3-5. However, microbubble susceptibility effect is relatively weak when compared with other 
intravascular MR susceptibility contrast agents. Previous theoretical and phantom studies have 
indicated that, by embedding or coating magnetic nanoparticles, the magnetic susceptibility of the shell 
can be increased4,6,7, thus enhancing the microbubble susceptibility effect. In this study, we aim to 
further demonstrate the synergistic effect of gas core with iron oxide nanoparticles in achieving the 
overall microbubble susceptibility effect and characterize in vivo enhancements of microbubble 
susceptibility effects by entrapping iron oxide nanoparticles using dynamic susceptibility weighted 
MRI at 7 T. 
METHODS 
All MRI experiments were performed on a 7 T Bruker MRI scanner. Synthesis of iron oxide 
nanoparticles entrapped polymeric microbubbles: Polymeric microbubbles (PMBs) with 
monocrystalline iron oxide nanoparticles (MIONs; MGH) incorporated or entrapped in shells were produced as 
previously described6 (Fig. 1). To demonstrate the synergistic effect of the gas core with MIONs, MION-entrapped 
solid microspheres (without gas core) were also prepared with the same procedures without performing lyophilization 
for comparison. Characterization of PMBs: ΔR2* was measured by acquiring multi-echo GE signals continuously 
without phase encoding for 2 min as previously described6. The absolute iron contents were determined with 
inductively coupled plasma mass spectrometry (ICP-MS) for MION-entrapped PMBs and solid microspheres. Their r2* 
relaxivities were computed as the R2* in the initial uniform suspended state normalized with their respective iron 
contents. Animal Preparation and Microbubbles Administration: Normal SD rats (~250-350 g) (N = 6) were injected 
intravenously with 0.2 mL of microbubble suspension (~3.5% volume fraction) at a rate of 0.6 mL/min to avoid 
possible microbubble destruction due to high pressure and shear stress under femoral vein catheterization. The 
susceptibility effect of microbubbles was compared with SonoVue® (Bracco), by single dose of ~3.5% volume fraction 
injection using identical injection protocol and imaging sequence. MRI: Anatomical images were acquired using 2D 
FLASH sequence with resolution = 0.2 × 0.2 × 2 mm3. Dynamic susceptibility weighted liver MRI was performed with 
respiratory-gated single-shot GE-EPI sequence using TR ≈ 1000 ms, TE = 10 ms, FA = 90º, FOV = 50 × 50 mm, slice 
thickness = 2 mm, acquisition matrix = 64 × 64, BW = 221 kHz and NEX = 1. Image Analysis: GE-EPI images were 
first co-registered using AIR5.2.58. ΔR2* maps were computed as previously described9. To quantify the ΔR2* values, 
ROIs were manually drawn in homogeneous liver region (LV) and the region covering blood vessel (BV) based on the 
high resolution FLASH images. Two-tail paired Student’s t test was employed to compare the liver ΔR2* induced by 
MION-free and MION-entrapped PMBs with p < 0.05 considered as statistically significant. Assuming that ΔR2* is 
proportional to microbubble concentration C(t) at time t, C(t) were approximately modeled with a gamma-variate 
function by curve fitting given the relatively long injection time and the limited lifetime of microbubbles in vivo5,9. Full 
width at half maximum (FWHM) and time-to-peak were then measured from the fitted C(t) time courses. 
RESULTS AND DISCUSSIONS 
Table 1 shows the measurements of the ∆R2* values and relaxivities for MION-entrapped PMBs (N = 6), MION-free 
PMBs (N = 6) and MION-entrapped microspheres (N = 2). ∆R2* for MION-entrapped PMBs was significantly higher 
than that of MION-free PMBs and MION-entrapped solid microspheres. The relaxivity results underscore the 
importance of both gas core and entrapped MIONs in achieving strong overall microbubble susceptibility effect, as 
suggested by the earlier theoretical study7. Figure 2(a) illustrates one of the preinjection GE-EPI T2*-weighted images, 
while (b) shows the corresponding postinjection GE-EPI T2*-weighted image with the maximum susceptibility contrast 
for MION-entrapped PMB injection. Figure 3 depicts the typical T2*-weighted signal time courses during PMBs 
injection with ROIs indicated in Fig. 2(a). Similar signal time course was also observed during MION-free PMB and 
SonoVue® injection. For MION-entrapped PMBs, the T2*-weighted signals after microbubble injection did not return 
to the preinjection baseline, this may be caused by accumulation of released MION in Kupffer cells after in vivo 
microbubble clearance. The computed ∆R2* maps for MION-free PMBs and MION-entrapped PMBs in the same 
animal were shown in Fig. 4, reflecting the blood distribution in tissue vasculature. Table 2 shows the in vivo 
measurements of the ∆R2*, FWHM and time-to-peak of MION-free PMBs, MION-entrapped PMBs and SonoVue® in 
liver among all rats studied. ∆R2* induced by MION-entrapped PMBs was found to be significantly higher than that by 
MION-free PMBs (p < 0.05), demonstrating that in vivo microbubble susceptibility can be enhanced by the MIONs 
entrapped in shells, as suggested by the earlier theoretical7 and phantom studies6. 
Table 1 Measurements of ∆R2* values and relaxivities for MION-free PMBs (N = 6), MION-
entrapped microspheres (N = 2), and MION-entrapped PMBs (N = 6) (mean ± standard error). 
 ΔR2* (s-1) Relaxivity (s-1/(μg Fe mL-1))
MION-free PMBs 79.2 ± 17.5 N.A.
MION-entrapped microspheres 82.5 ± 3.6 7.2
MION-entrapped PMBs 301.2 ± 16.8 21.0
 
Table 2 Measurements of ∆R2*, FWHM and time-to-peak of the concentration time courses 
for MION-free, MION-entrapped PMBs and SonoVue® in rat liver (N = 6) (mean ± SD). 
ΔR2* (s-1) FWHM (s) Time-to-peak (s)
MION-free PMBs 19.9 ± 14.5 81 ± 43 107 ± 31
MION-entrapped PMBs 28.9 ± 16.3 120 ± 76 100 ± 23
SonoVue® 9.4 ± 3.5 148 ± 59 141 ± 62
 
CONCLUSIONS  
In this study, synergistic effect of gas core with iron oxide nanoparticles in achieving the overall microbubble susceptibility effect were shown, considerable 
susceptibility induced changes were observed and characterized in rat liver using MION-free and MION-entrapped PMBs, as well as SonoVue®. We demonstrated that 
entrapping iron oxide nanoparticles in polymeric microbubbles is feasible to significantly enhance magnetic susceptibility effects. With such approach, microbubbles 
can be monitored by MRI with higher sensitivity or lower concentrations, which may lead to the practical use of microbubbles as an intravascular MRI contrast agent, 
and MRI guidance in various microbubble-based drug delivery and therapeutic applications. 
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FIG. 1 Flow diagram representing the adapted double emulsion 
method for synthesizing iron oxide nanoparticles entrapped 
polymeric microbubbles (PMBs). 
FIG. 2 GE-EPI T2*-weighted image for MION-
entrapped PMB (0.2 mL of ~3.5% volume fraction) 
(a) preinjection image and (b) postinjection with 
the maximum susceptibility contrast.
FIG. 3 T2*-weighted signal time courses in 
different liver regions during MION-entrapped 
PMB injection in the same rat. Two ROIs for time 
course measurement are shown in Fig. 1(a). 
Gamma-variate fitted data are shown in sold lines.
FIG. 4 ∆R2* maps for (a) MION-free and (b) 
MION-entrapped PMBs.
